The Pharmacologic Assessment of A Novel Lymphocyte Function-Associated Antigen-1 Antagonist (SAR 1118) for the Treatment of Keratoconjunctivitis Sicca in Dogs - Concepedia

Concepedia

Publication | Closed Access

The Pharmacologic Assessment of A Novel Lymphocyte Function-Associated Antigen-1 Antagonist (SAR 1118) for the Treatment of Keratoconjunctivitis Sicca in Dogs

81

Citations

20

References

2011

Year

Christopher J. Murphy, Ellison Bentley, P. Elliott Miller, Kim McIntyre, Gary Leatherberry, Richard R. Dubielzig, Elizabeth A. Giuliano, Cecil P. Moore, Thomas E. Phillips, P.Blaise Smith,

Investigative Ophthalmology & Visual Science

Abstract

SAR 1118 appears to be an effective anti-inflammatory treatment for KCS. Additional studies are warranted to establish the efficacy of SAR 1118 for the treatment of KCS in humans.

References

	Year	Citations

Page 1